In another instance of unseemly marketing, a unit of Allergan has agreed to pay $38 million to settle allegations of paying kickbacks to encourage doctors to prescribe four its medicines.
As with other drug makers accused of the same practices, the company allegedly rewarded high-prescribing doctors with speaking engagements and these were billed as educational sessions. But in reality, these were often held in fancy restaurants simply to woo still other doctors to attend, according to a whistleblower lawsuit that was filed in 2012 by a former sales rep for Forest Pharmaceuticals, which was later acquired by Allergan.
About the Author Reprints
